Traders sold shares of Johnson & Johnson (NYSE:JNJ) on strength during trading hours on Tuesday. $305.41 million flowed into the stock on the tick-up and $331.07 million flowed out of the stock on the tick-down, for a money net flow of $25.66 million out of the stock. Of all companies tracked, Johnson & Johnson had the 19th highest net out-flow for the day. Johnson & Johnson traded up $2.11 for the day and closed at $125.25

Several equities analysts recently commented on the company. JPMorgan Chase & Co. reissued a “hold” rating on shares of Johnson & Johnson in a research report on Sunday, April 17th. Royal Bank Of Canada restated a “buy” rating on shares of Johnson & Johnson in a report on Sunday, April 17th. BTIG Research restated a “hold” rating on shares of Johnson & Johnson in a report on Sunday, May 22nd. Leerink Swann restated a “buy” rating on shares of Johnson & Johnson in a report on Sunday, May 22nd. Finally, Piper Jaffray Cos. lifted their price objective on Johnson & Johnson from $105.00 to $106.00 and gave the stock a “neutral” rating in a report on Wednesday, April 20th. Two analysts have rated the stock with a sell rating, twelve have assigned a hold rating and nine have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average target price of $112.77.

The stock has a market capitalization of $344.52 billion and a price-to-earnings ratio of 22.83. The firm’s 50 day moving average is $118.60 and its 200 day moving average is $109.95.

Johnson & Johnson (NYSE:JNJ) last announced its quarterly earnings data on Tuesday, July 19th. The company reported $1.74 EPS for the quarter, topping the Zacks’ consensus estimate of $1.69 by $0.05. The firm earned $18.50 billion during the quarter, compared to the consensus estimate of $17.98 billion. Equities research analysts forecast that Johnson & Johnson will post $6.61 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 6th. Shareholders of record on Tuesday, August 23rd will be given a $0.80 dividend. The ex-dividend date of this dividend is Friday, August 19th. This represents a $3.20 dividend on an annualized basis and a dividend yield of 2.55%.

In related news, VP Gary J. Pruden sold 9,735 shares of the business’s stock in a transaction on Tuesday, June 7th. The stock was sold at an average price of $116.03, for a total value of $1,129,552.05. Following the sale, the vice president now owns 43,630 shares of the company’s stock, valued at approximately $5,062,388.90. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CAO Ronald A. Kapusta sold 3,000 shares of the business’s stock in a transaction on Tuesday, June 7th. The shares were sold at an average price of $115.79, for a total value of $347,370.00. Following the completion of the sale, the chief accounting officer now directly owns 28,725 shares in the company, valued at approximately $3,326,067.75. The disclosure for this sale can be found here.

A number of hedge funds recently made changes to their positions in the stock. Heritage Wealth Advisors raised its stake in shares of Johnson & Johnson by 3.3% in the fourth quarter. Heritage Wealth Advisors now owns 9,944 shares of the company’s stock valued at $1,021,000 after buying an additional 317 shares in the last quarter. Lourd Capital LLC increased its position in shares of Johnson & Johnson by 8.3% in the fourth quarter. Lourd Capital LLC now owns 11,115 shares of the company’s stock valued at $1,142,000 after buying an additional 851 shares during the last quarter. Eidelman Virant Capital increased its position in shares of Johnson & Johnson by 11.8% in the fourth quarter. Eidelman Virant Capital now owns 11,623 shares of the company’s stock valued at $1,193,000 after buying an additional 1,231 shares during the last quarter. Wedgewood Investors Inc. PA increased its position in shares of Johnson & Johnson by 0.4% in the fourth quarter. Wedgewood Investors Inc. PA now owns 11,883 shares of the company’s stock valued at $1,221,000 after buying an additional 50 shares during the last quarter. Finally, Nelson Van Denburg & Campbell Wealth Management Group LLC increased its position in shares of Johnson & Johnson by 9.9% in the fourth quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC now owns 13,032 shares of the company’s stock valued at $1,339,000 after buying an additional 1,179 shares during the last quarter.

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company’s segments include Consumer, Pharmaceutical and Medical Devices. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women’s health and wound care markets.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.